We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$93.4B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+16.68%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$84.1B
AUM Growth
+$9.18B
(+12%)
Cap. Flow
-$125M
Cap. Flow
% of AUM
-0.15%
Top 10 Holdings %
Top 10 Hldgs %
33.22%
Holding
3,151
New
699
Increased
893
Reduced
848
Closed
646
Top Buys
| 1 |
CRCL
Circle Internet Group
CRCL
|
+$1.39B |
| 2 |
NVIDIA
NVDA
|
+$910M |
| 3 |
Amazon
AMZN
|
+$440M |
| 4 |
T-Mobile US
TMUS
|
+$432M |
| 5 |
Eli Lilly
LLY
|
+$398M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.3B |
| 2 |
Tesla
TSLA
|
+$880M |
| 3 |
Danaher
DHR
|
+$535M |
| 4 |
Intuit
INTU
|
+$467M |
| 5 |
Visa
V
|
+$437M |
Sector Composition
| 1 | Technology | 20.99% |
| 2 | Consumer Discretionary | 14.3% |
| 3 | Healthcare | 11% |
| 4 | Financials | 9.27% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Inogen
INGN
$171M
| $184K | ﹤0.01% |
26,181
-16,004
| -38% | -$108K |
|
2302
Taysha Gene Therapies
TSHA
$1.62B
| $184K | ﹤0.01% |
+79,498
| New | +$173K |
|
2303
US Gold Corp
USAU
$251M
| $183K | ﹤0.01% |
15,028
+287
| +2% | +$3.16K |
|
2304
Neumora Therapeutics
NMRA
$304M
| $183K | ﹤0.01% |
+250,490
| New | +$190K |
|
|
LADR
2305
Ladder Capital
LADR
$1.25B
| $183K | ﹤0.01% |
+17,005
| New | +$179K |
|
|
YMAB
2306
DELISTED
Y-mAbs Therapeutics
YMAB
| $181K | ﹤0.01% |
+40,181
| New | +$181K |
|
2307
Five Point Holdings
FPH
$375M
| $181K | ﹤0.01% |
32,834
-15,314
| -32% | -$82K |
|
2308
Relay Therapeutics
RLAY
$4.11B
| $179K | ﹤0.01% |
+51,698
| New | +$154K |
|
2309
Leslie's
LESL
$29.5M
| $177K | ﹤0.01% |
21,064
+18,534
| +733% | +$244K |
|
2310
Gencor Industries
GENC
$226M
| $176K | ﹤0.01% |
12,540
-13,764
| -52% | -$180K |
|
2311
LiveOne
LVO
$74.2M
| $174K | ﹤0.01% |
+23,144
| New | +$172K |
|
2312
Grupo Aval
AVAL
$6.02B
| $171K | ﹤0.01% |
60,733
+25,753
| +74% | +$70.6K |
|
2313
Evotec
EVO
$710M
| $169K | ﹤0.01% |
+40,310
| New | +$158K |
|
|
USAS
2314
Americas Gold and Silver
USAS
$1.39B
| $169K | ﹤0.01% |
83,440
-194,164
| -70% | -$314K |
|
2315
Sutro Biopharma
STRO
$429M
| $166K | ﹤0.01% |
+23,443
| New | +$192K |
|
|
CLPR
2316
Clipper Realty
CLPR
$46.5M
| $165K | ﹤0.01% |
44,987
+1,269
| +3% | +$4.85K |
|
2317
AbCellera Biologics
ABCL
$2.05B
| $163K | ﹤0.01% |
47,480
| – | – |
|
2318
Pyxis Oncology
PYXS
$146M
| $163K | ﹤0.01% |
+147,771
| New | +$166K |
|
2319
Digimarc Corp
DMRC
$156M
| $162K | ﹤0.01% |
12,276
-101,974
| -89% | -$1.31M |
|
|
QIPT
2320
DELISTED
Quipt Home Medical
QIPT
| $162K | ﹤0.01% |
+90,514
| New | +$179K |
|
2321
Wave Life Sciences
WVE
$1.15B
| $161K | ﹤0.01% |
+24,828
| New | +$164K |
|
2322
Mammoth Energy Services
TUSK
$135M
| $161K | ﹤0.01% |
+57,436
| New | +$147K |
|
2323
Lufax Holding
LU
$1.16B
| $160K | ﹤0.01% |
+57,404
| New | +$162K |
|
2324
Acumen Pharmaceuticals
ABOS
$173M
| $160K | ﹤0.01% |
+137,943
| New | +$148K |
|
2325
Invivyd
IVVD
$235M
| $158K | ﹤0.01% |
+222,633
| New | +$158K |
|
Similar funds
